Evidence map›Paper›PMID 40661629›Full record

ArticlebioRxiv : the preprint server for biology2025

Motor protein disruption critically alters organelle trafficking, NMJ formation, and excitation contraction coupling.

H Bansal, T A Hana, A H Michael, S Kamaridinova, J Bransford, K G Ormerod

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

H Bansal
T A Hana
A H Michael
S Kamaridinova
J Bransford

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Trafficking of intracellular cargoes along the neuronal axon microtubule tracks is a motor-protein-dependent process. It is well-established that the motor protein kinesin is responsible for anterograde trafficking of axonal cargo, while the dynein/dynactin complex regulates retrograde trafficking. However, there is still much to uncover regarding the various isoforms of these motor proteins as well as the adapter and cargo-associated proteins involved in the precise trafficking dynamics. Here we use a targeted genetic approach to knockdown candidate kinesin genes involved in trafficking organelles like synaptic vesicles, mitochondria, and dense core vesicles in motor neurons. Using fluorescently tagged cargo proteins; live-imaging experiments were conducted to quantify intracellular trafficking changes, and 2 genes, kinesins 1 and 3, were identified as critical regulators. Disruptions in either gene product, reduce rates of axonal trafficking in motor neurons, and lead to the formation of large intracellular aggregates in somas and axons. Downstream, disruptions in both kinesin 1 and 3 expression led to significant changes in neuropeptide (NP) abundance at boutons, and changes in synaptic morphology, including innervation length, bouton number, and active zone composition. Spinning disc confocal imaging revealed fewer NP trafficking through, or getting captured in kinesin knockdown experiments, and a dramatic reduction in NP release at motor neuron terminals. We go on to show profound reductions in neuromuscular transduction, and excitation-contraction coupling in kinesin 1 knockdowns, but not for kinesin 3. Changes in larval crawling as well as development were observed for kinesin 1 knockdowns. Taken together we have not only identified which kinesins are critically involved in organelle trafficking, but also revealed critical disruptions in cellular morphology, function, physiology, and behavior in genetically disrupted animals.

Identifiers

PMID40661629
PMCPMC12259078

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.